• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

快速进展性痴呆 - 病因、诊断和治疗。

Rapidly progressive dementias - aetiologies, diagnosis and management.

机构信息

Department of Neurology, Clinical Dementia Center and National Reference Center for CJD Surveillance, University Medical Center, Göttingen, Germany.

German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.

出版信息

Nat Rev Neurol. 2022 Jun;18(6):363-376. doi: 10.1038/s41582-022-00659-0. Epub 2022 May 4.

DOI:10.1038/s41582-022-00659-0
PMID:35508635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9067549/
Abstract

Rapidly progressive dementias (RPDs) are a group of heterogeneous disorders that include immune-mediated, infectious and metabolic encephalopathies, as well as prion diseases and atypically rapid presentations of more common neurodegenerative diseases. Some of these conditions are treatable, and some must be diagnosed promptly because of their potential infectivity. Prion disease is considered to be the prototypical RPD, but over the past two decades, epidemiological reports and the identification of various encephalitis-mediating antibodies have led to a growing recognition of other encephalopathies as potential causes of rapid cognitive decline. Knowledge of RPD aetiologies, syndromes and diagnostic work-up protocols will help clinicians to establish an early, accurate diagnosis, thereby reducing morbidity and mortality, especially in immune-mediated and other potentially reversible dementias. In this Review, we define the syndrome of RPD and shed light on its different aetiologies and on secondary factors that might contribute to rapid cognitive decline. We describe an extended diagnostic procedure in the context of important differential diagnoses, discuss the utility of biomarkers and summarize potential treatment options. In addition, we discuss treatment options such as high-dose steroid therapy in the context of therapy and diagnosis in clinically ambiguous cases.

摘要

快速进展性痴呆(RPD)是一组异质性疾病,包括免疫介导、感染和代谢性脑病,以及朊病毒病和更常见神经退行性疾病的非典型快速表现。其中一些疾病是可治疗的,而有些疾病由于其潜在传染性必须迅速诊断。朊病毒病被认为是典型的 RPD,但在过去的二十年中,流行病学报告和各种脑炎介导抗体的鉴定导致人们越来越认识到其他脑病可能是导致快速认知衰退的原因。了解 RPD 的病因、综合征和诊断检查方案将有助于临床医生尽早做出准确诊断,从而降低发病率和死亡率,尤其是在免疫介导和其他潜在可逆转的痴呆症中。在这篇综述中,我们定义了 RPD 综合征,并探讨了其不同的病因以及可能导致快速认知衰退的次要因素。我们在重要的鉴别诊断背景下描述了扩展的诊断程序,讨论了生物标志物的效用,并总结了潜在的治疗选择。此外,我们还讨论了在临床情况下具有模糊性的情况下治疗和诊断中类固醇激素治疗等治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461f/9067549/4455fc182c93/41582_2022_659_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461f/9067549/74b5de9e5acc/41582_2022_659_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461f/9067549/500522732e81/41582_2022_659_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461f/9067549/4455fc182c93/41582_2022_659_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461f/9067549/74b5de9e5acc/41582_2022_659_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461f/9067549/500522732e81/41582_2022_659_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461f/9067549/4455fc182c93/41582_2022_659_Fig3_HTML.jpg

相似文献

1
Rapidly progressive dementias - aetiologies, diagnosis and management.快速进展性痴呆 - 病因、诊断和治疗。
Nat Rev Neurol. 2022 Jun;18(6):363-376. doi: 10.1038/s41582-022-00659-0. Epub 2022 May 4.
2
Diagnostic challenges in rapidly progressive dementia.快速进展性痴呆的诊断挑战。
Expert Rev Neurother. 2018 Oct;18(10):761-772. doi: 10.1080/14737175.2018.1519397. Epub 2018 Sep 17.
3
Rapidly Progressive Dementia.快速进展性痴呆
Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):510-37. doi: 10.1212/CON.0000000000000319.
4
Rapidly progressive dementia.快速进展性痴呆
Ann Neurol. 2008 Jul;64(1):97-108. doi: 10.1002/ana.21430.
5
Differential diagnosis with other rapid progressive dementias in human prion diseases.人类朊病毒病与其他快速进展性痴呆的鉴别诊断。
Handb Clin Neurol. 2018;153:371-397. doi: 10.1016/B978-0-444-63945-5.00020-9.
6
The evaluation of rapidly progressive dementia.快速进展性痴呆的评估
Neurologist. 2011 Mar;17(2):67-74. doi: 10.1097/NRL.0b013e31820ba5e3.
7
Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies.快速进展性痴呆的神经影像学检查,第1部分:神经退行性病因
AJNR Am J Neuroradiol. 2014 Mar;35(3):418-23. doi: 10.3174/ajnr.A3454. Epub 2013 Feb 22.
8
Diagnosis of Rapidly Progressive Dementia in a Referral Center in Argentina.阿根廷转诊中心快速进展性痴呆的诊断。
Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):54-58. doi: 10.1097/WAD.0000000000000337.
9
Neuroimaging of rapidly progressive dementias, part 2: prion, inflammatory, neoplastic, and other etiologies.快速进展性痴呆的神经影像学,第2部分:朊病毒、炎症性、肿瘤性及其他病因
AJNR Am J Neuroradiol. 2014 Mar;35(3):424-31. doi: 10.3174/ajnr.A3455. Epub 2013 Feb 14.
10
Rapidly progressive dementias and the treatment of human prion diseases.快速进展性痴呆和人类朊病毒病的治疗。
Expert Opin Pharmacother. 2011 Jan;12(1):1-12. doi: 10.1517/14656566.2010.514903. Epub 2010 Nov 23.

引用本文的文献

1
Pathogenic Proteins Through the Lens of NMR Spectroscopy: Structural and Functional Insights into Disease.核磁共振波谱视角下的致病蛋白:对疾病的结构与功能洞察
Cell Biochem Biophys. 2025 Aug 13. doi: 10.1007/s12013-025-01869-1.
2
Diagnostic Odyssey: Primary CNS Lymphoma (Lymphoma Cerebri) Presenting as Rapidly Progressive Dementia.诊断历程:表现为快速进展性痴呆的原发性中枢神经系统淋巴瘤(脑淋巴瘤)
Case Rep Hematol. 2025 Jul 9;2025:8819799. doi: 10.1155/crh/8819799. eCollection 2025.
3
Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia.

本文引用的文献

1
Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer's disease.在快速进展的阿尔茨海默病中存在具有高潜力 TAU 种子构象的不同群体。
Sci Transl Med. 2022 Jan 5;14(626):eabg0253. doi: 10.1126/scitranslmed.abg0253.
2
Molecular Profiles of Amyloid-β Proteoforms in Typical and Rapidly Progressive Alzheimer's Disease.典型和快速进展性阿尔茨海默病中淀粉样β蛋白异构体的分子特征。
Mol Neurobiol. 2022 Jan;59(1):17-34. doi: 10.1007/s12035-021-02566-9. Epub 2021 Oct 7.
3
Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach.
解读疑似快速进展性痴呆患者中与病情进展、病因及预后相关的临床特征。
Ann Neurol. 2025 Jun 20. doi: 10.1002/ana.27297.
4
Structural exposure of different microtubule binding domains determines the propagation and toxicity of pathogenic tau conformers in Alzheimer's disease.不同微管结合结构域的结构暴露决定了阿尔茨海默病中致病性tau构象异构体的传播和毒性。
PLoS Pathog. 2025 Jun 13;21(6):e1012926. doi: 10.1371/journal.ppat.1012926. eCollection 2025 Jun.
5
Sex differences in risk factors for Alzheimer dementia encephalopathy patients.阿尔茨海默病性痴呆脑病患者危险因素中的性别差异。
Front Dement. 2025 May 26;4:1593788. doi: 10.3389/frdem.2025.1593788. eCollection 2025.
6
Digital Dementia Education and Training for Informal Carers: A Scoping Review.针对非正式照料者的数字痴呆症教育与培训:一项范围综述
J Clin Nurs. 2025 Oct;34(10):3981-3994. doi: 10.1111/jocn.17817. Epub 2025 May 28.
7
Synapse vulnerability and resilience across the clinical spectrum of dementias.痴呆症临床谱系中的突触易损性与恢复力
Nat Rev Neurol. 2025 May 22. doi: 10.1038/s41582-025-01094-7.
8
Development and validation of a novel predictive model for dementia risk in middle-aged and elderly depression individuals: a large and longitudinal machine learning cohort study.中老年抑郁症患者痴呆风险新型预测模型的开发与验证:一项大型纵向机器学习队列研究
Alzheimers Res Ther. 2025 May 13;17(1):103. doi: 10.1186/s13195-025-01750-6.
9
Mechanistic Insights into the Neuroprotective Potential of (L.) Correa Fruits against Aβ-Induced Cell Toxicity in Human Neuroblastoma SH-SY5Y Cells.(L.)科雷亚果实对人神经母细胞瘤SH-SY5Y细胞中Aβ诱导的细胞毒性的神经保护潜力的机制性见解。
Pharmaceuticals (Basel). 2025 Mar 28;18(4):489. doi: 10.3390/ph18040489.
10
Neurodegeneration and the immune system: lessons from autoimmune encephalitis.神经退行性变与免疫系统:自身免疫性脑炎的启示
J Neurol. 2025 Apr 24;272(5):359. doi: 10.1007/s00415-025-13094-0.
成人自身抗体相关的精神症状和综合征:一项叙述性综述及建议的诊断方法。
Brain Behav Immun Health. 2020 Oct 1;9:100154. doi: 10.1016/j.bbih.2020.100154. eCollection 2020 Dec.
4
Can we learn lessons from the FDA's approval of aducanumab?我们能否从 FDA 批准 aducanumab 中吸取教训?
Nat Rev Neurol. 2021 Nov;17(11):715-722. doi: 10.1038/s41582-021-00557-x. Epub 2021 Sep 17.
5
Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis.脑功能障碍与甲状腺抗体:自身免疫性诊断与误诊
Brain Commun. 2021 Jan 5;3(2):fcaa233. doi: 10.1093/braincomms/fcaa233. eCollection 2021.
6
Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings.自身免疫性全面性遗忘症作为 AMPAR 脑炎的表现及神经病理学发现。
Neurol Neuroimmunol Neuroinflamm. 2021 May 20;8(4). doi: 10.1212/NXI.0000000000001019. Print 2021 Jul.
7
The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.不断进行克雅氏病国际监测的重要性。
Nat Rev Neurol. 2021 Jun;17(6):362-379. doi: 10.1038/s41582-021-00488-7. Epub 2021 May 10.
8
Cerebrospinal Fluid Pleocytosis Not Attributable to Status Epilepticus in First 24 Hours.24 小时内无癫痫持续状态相关的脑脊液白细胞增多。
Can J Neurol Sci. 2022 Mar;49(2):210-217. doi: 10.1017/cjn.2021.83. Epub 2021 Apr 27.
9
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.散发性克雅氏病的生物标志物和诊断指南。
Lancet Neurol. 2021 Mar;20(3):235-246. doi: 10.1016/S1474-4422(20)30477-4.
10
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial.原发性中枢神经系统淋巴瘤患者的神经认知功能和影像学改变:HOVON 105/ALLG NHL 24 随机对照试验结果。
Neuro Oncol. 2021 Aug 2;23(8):1315-1326. doi: 10.1093/neuonc/noab021.